Bv probiotics
Pro Research Analysisby 
Searched over 200M research papers for "bv probiotics"
Probiotics for Bacterial Vaginosis (BV): Efficacy and Safety
Introduction to Bacterial Vaginosis and Probiotics
Bacterial vaginosis (BV) is a common vaginal condition caused by an imbalance in the vaginal microbiota, leading to symptoms such as discharge, odor, and discomfort. Traditional treatments often involve antibiotics, but recurrence rates are high. Probiotics, which are beneficial bacteria, have been explored as an alternative or complementary treatment to restore healthy vaginal flora.
Efficacy of Probiotics in Treating BV
Probiotics vs. Placebo
Several studies have demonstrated that probiotics can be effective in treating BV when compared to a placebo. A meta-analysis of randomized controlled trials (RCTs) found that probiotics significantly improved the clinical cure rate and Nugent score, a diagnostic measure for BV, compared to placebo treatments2. Another study confirmed that probiotics reduced the Nugent score and suppressed harmful bacteria such as Gardnerella vaginalis after 12 weeks of treatment3.
Probiotics vs. Antibiotics
When comparing probiotics to antibiotics, the results are mixed. Some studies indicate that probiotics alone may not be as effective as antibiotics in treating BV1. However, probiotics combined with antibiotics have shown improved outcomes. For instance, a combination of probiotics and antibiotics resulted in a higher cure rate compared to antibiotics alone1 6.
Probiotics as a Complementary Therapy
Probiotics used alongside antibiotics have been shown to enhance treatment efficacy and reduce recurrence rates. A systematic review found that probiotics reduced the risk of BV recurrence by 45% when used after antibiotic treatment4. Another study highlighted that probiotics administered intravaginally in conjunction with antibiotics significantly improved cure rates and reduced inflammation7.
Safety and Long-term Benefits
Short-term and Long-term Effects
Probiotics are generally safe and well-tolerated, with no significant adverse events reported in the studies reviewed2 3 5. They have been shown to provide both short-term and long-term benefits. For example, a study on the probiotic MED-01 demonstrated significant improvements in vaginal health over a 12-week period3. Another study found that short-term probiotic prophylaxis reduced BV recurrence and the incidence of Gardnerella vaginalis for up to 11 months7.
Ethnic and Regional Variations
The effectiveness of probiotics may vary based on the population studied. One meta-analysis suggested that the beneficial effects of probiotics post-antibiotics were more pronounced in studies with a predominantly black population2. Additionally, a study on Chinese women found that while probiotics did not significantly improve BV cure rates, they were effective in restoring vaginal health post-treatment10.
Conclusion
Probiotics offer a promising alternative or complementary treatment for bacterial vaginosis. They have been shown to improve clinical outcomes, reduce recurrence rates, and are generally safe for use. However, the efficacy of probiotics can vary based on the population and specific strains used. Further high-quality, standardized RCTs are needed to fully establish the role of probiotics in BV treatment and prevention.
Sources and full results
Most relevant research papers on this topic
Probiotics for the treatment of women with bacterial vaginosis: A systematic review and meta-analysis of randomized clinical trials.
Probiotics may have a positive effect on treating bacterial vaginosis, but strong evidence is lacking for their effectiveness.
Meta-Analysis
Rigorous JournalProbiotics for the Treatment of Bacterial Vaginosis: A Meta-Analysis
Probiotics are safe and may have a short-term and long-term beneficial effect for bacterial vaginosis treatment, with a possible ethnic-specific effect after antibiotics.
Meta-AnalysisRigorous JournalEfficacy and Safety of MED-01 Probiotics on Vaginal Health: A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
MED-01 probiotics effectively improve vaginal health and reduce bacterial vaginosis in reproductive-aged women, with no adverse events observed.
RCTProbiotics, a promising therapy to reduce the recurrence of bacterial vaginosis in women? a systematic review and meta-analysis of randomized controlled trials
Probiotics effectively reduce the risk of bacterial vaginosis recurrences by 45% compared to placebo or metronidazole in women aged 18 years and above.
Meta-AnalysisEffects of Pro/Prebiotics Alone over Pro/Prebiotics Combined with Conventional Antibiotic Therapy to Treat Bacterial Vaginosis: A Systematic Review
Pre/probiotic regimens are generally safe and can exhibit long-term and short-term benefits in treating bacterial vaginosis in both pregnant and nonpregnant women.
Systematic ReviewRigorous JournalProbiotics in addition to metronidazole for treatment Trichomonas vaginalis in the presence of BV: a randomized, placebo-controlled, double-blind study
Adding probiotics to metronidazole therapy for Trichomonas vaginalis in the presence of Bacteroides fragilis increases the likelihood of cure and improves vaginal pH and redox potential.
RCTRigorous JournalEfficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study.
Vaginal probiotic capsules effectively reduce bacterial vaginosis recurrence and Gardnerella vaginalis risk in women through 11 months of treatment.
RCT
Highly CitedProbiotics administered intravaginally as a complementary therapy combined with antibiotics for the treatment of bacterial vaginosis: a systematic review protocol
Lactobacilli administered intravaginally in conjunction with antibiotics may improve cure rates and reduce recurrence rates in treating bacterial vaginosis.
Systematic ReviewRigorous JournalEffects of Probiotics on the Recurrence of Bacterial Vaginosis: A Review
Probiotics, particularly Lactobacillus acidophilus, Lactobacillus rhamnosus GR-1, and Lactobacillus fermentum RC-14, show promise in preventing and treating bacterial vaginosis in women, with no reported adverse effects.
Systematic ReviewHighly CitedOrally administrated Lactobacillus gasseri TM13 and Lactobacillus crispatus LG55 can restore the vaginal health of patients recovering from bacterial vaginosis
Orally administered Lactobacillus gasseri TM13 and Lactobacillus crispatus LG55 can restore vaginal health in patients recovering from bacterial vaginosis, but individualized interventions are needed to improve cure rates.
RCT